"The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals general oral solid formulation facility located at Panelav from 9-13 March, 2020," the drug firm said in a filing to the BSE. This was a scheduled inspection, and at the end of the inspection, the USFDA issued a Form 483 with four procedural observations.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2wei1F1
via IFTTT
Subscribe to:
Post Comments (Atom)
-
On Sunday, 68 new cases were reported by 14 states in all, the second highest for a single day after 77 cases reported on Saturday. from T...
-
How to keep yourself away from the novel coronavirus? (1) 2019-nCoV is mainly transmitted by droplets and contacts, therefore medical su...
-
By Reuters via NYT World https://ift.tt/2vrReVu
No comments:
Post a Comment